Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label

3 weeks ago

PALO ALTO, Calif., Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- Scilex Holding Company ( Nasdaq: SCLX, "Scilex" or the "Company" ) , an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic ...

Ticker	Sentiment	Impact
SCLX	Neutral	51 %